2014
Biomet’s Q2 profits surge on lower legal costs
Biomet reported surging 2nd-quarter profits today, saying a 61% reduction in legal costs drove the increase.
Synergetics pays $14m for Sterimedix
Synergetics (NSDQ:SURG) said yesterday that it acquired a U.K.-based cannulae and needles maker, Sterimedix, for $13.5 million and announced lower-than-expected earnings for its fiscal 1st quarter.
Year in review: 2014 was the year of the medtech IPO
Medtronic hits 52-week high on strong Q2 results
Medtronic’s Q2 results meet The Street
CareFusion’s Q1 sales, earnings rise
CareFusion (NYSE:CFN) ended its last fiscal quarter as a public company on a strong note, posting earnings growth of 2.8% on a top-line gain of 11.1%.